Literature DB >> 28747368

Fusarium Keratitis in Germany.

Grit Walther1, Serena Stasch2, Kerstin Kaerger2, Axel Hamprecht3, Mathias Roth4, Oliver A Cornely5,6,7, Gerd Geerling4, Colin R Mackenzie8, Oliver Kurzai2,9, Marie von Lilienfeld-Toal2,10.   

Abstract

Fusarium keratitis is a destructive eye infection that is difficult to treat and results in poor outcome. In tropical and subtropical areas, the infection is relatively common and associated with trauma or chronic eye diseases. However, in recent years, an increased incidence has been reported in temperate climate regions. At the German National Reference Center, we have observed a steady increase in case numbers since 2014. Here, we present the first German case series of eye infections with Fusarium species. We identified Fusarium isolates from the eye or eye-related material from 22 patients in 2014 and 2015. Thirteen isolates belonged to the Fusarium solani species complex (FSSC), 6 isolates belonged to the Fusarium oxysporum species complex (FOSC), and three isolates belonged to the Fusarium fujikuroi species complex (FFSC). FSSC was isolated in 13 of 15 (85%) definite infections and FOSC in 3 of 4 (75%) definite contaminations. Furthermore, diagnosis from contact lens swabs or a culture of contact lens solution turned out to be highly unreliable. FSSC isolates differed from FOSC and FFSC by a distinctly higher MIC for terbinafine. Outcome was often adverse, with 10 patients requiring keratoplasty or enucleation. The use of natamycin as the most effective agent against keratitis caused by filamentous fungi was rare in Germany, possibly due to restricted availability. Keratitis caused by Fusarium spp. (usually FSSC) appears to be a relevant clinical problem in Germany, with the use of contact lenses as the predominant risk factor. Its outcome is often adverse.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Fusarium; antifungal susceptibility testing; contact lens; fungal keratitis

Mesh:

Substances:

Year:  2017        PMID: 28747368      PMCID: PMC5625384          DOI: 10.1128/JCM.00649-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  58 in total

1.  Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.

Authors:  Mónika Homa; Coimbatore S Shobana; Yendrembam R B Singh; Palanisamy Manikandan; Kanesan P Selvam; László Kredics; Venkatapathy Narendran; Csaba Vágvölgyi; László Galgóczy
Journal:  Mycoses       Date:  2013-02-26       Impact factor: 4.377

2.  Multidrug resistant Fusarium keratitis.

Authors:  P Antequera; V Garcia-Conca; C Martín-González; V Ortiz-de-la-Tabla
Journal:  Arch Soc Esp Oftalmol       Date:  2014-11-14

3.  Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.

Authors:  Abdullah M S Al-Hatmi; Anne D van Diepeningen; Ilse Curfs-Breuker; G Sybren de Hoog; Jacques F Meis
Journal:  J Antimicrob Chemother       Date:  2014-12-23       Impact factor: 5.790

Review 4.  Medical interventions for fungal keratitis.

Authors:  Nilo Vincent FlorCruz; Ildefonso V Peczon; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

5.  Contact lens-associated fusarium keratitis in Switzerland.

Authors:  C Kaufmann; B E Frueh; J Messerli; W Bernauer; M A Thiel
Journal:  Klin Monbl Augenheilkd       Date:  2008-05       Impact factor: 0.700

6.  Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Authors:  Rafael A Oechsler; Michael R Feilmeier; Darlene Miller; Wei Shi; Ana Luisa Hofling-Lima; Eduardo C Alfonso
Journal:  Cornea       Date:  2013-05       Impact factor: 2.651

Review 7.  Fusarium keratitis and contact lens wear: facts and speculations.

Authors:  Donald G Ahearn; Shangtong Zhang; R Doyle Stulting; Brian L Schwam; Robert B Simmons; Michael A Ward; George E Pierce; Sidney A Crow
Journal:  Med Mycol       Date:  2008-04-04       Impact factor: 4.076

8.  International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.

Authors:  A Espinel-Ingroff; A L Colombo; S Cordoba; P J Dufresne; J Fuller; M Ghannoum; G M Gonzalez; J Guarro; S E Kidd; J F Meis; T M S C Melhem; T Pelaez; M A Pfaller; M W Szeszs; J P Takahaschi; A M Tortorano; N P Wiederhold; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

9.  Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species.

Authors:  R Vilgalys; M Hester
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

10.  Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006.

Authors:  Kerry O'Donnell; Brice A J Sarver; Mary Brandt; Douglas C Chang; Judith Noble-Wang; Benjamin J Park; Deanna A Sutton; Lynette Benjamin; Mark Lindsley; Arvind Padhye; David M Geiser; Todd J Ward
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

View more
  32 in total

1.  Invasive Fungal Infection.

Authors:  Marie von Lilienfeld-Toal; Johannes Wagener; Hermann Einsele; Oliver A Cornely; Oliver Kurzai
Journal:  Dtsch Arztebl Int       Date:  2019-04-19       Impact factor: 5.594

2.  Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.

Authors:  Ananya Tupaki-Sreepurna; Vijayakishore Thanneru; Sangeetha Natarajan; Savitri Sharma; Anjana Gopi; Murugan Sundaram; Anupma Jyoti Kindo
Journal:  Mycopathologia       Date:  2018-02-14       Impact factor: 2.574

3.  The facilitating effect of blue light on the antifungal agent susceptibilities of passaged conidia from the ocular-derived Fusarium solani species complex.

Authors:  Yujie Cen; Yingyu Li; Pei Zhang; Ziyuan Liu; Chen Huang; Wei Wang
Journal:  Lasers Med Sci       Date:  2022-01-29       Impact factor: 3.161

Review 4.  Clinical utility of antifungal susceptibility testing.

Authors:  Todd P McCarty; Paul M Luethy; John W Baddley; Peter G Pappas
Journal:  JAC Antimicrob Resist       Date:  2022-06-28

5.  Comparative genomic and transcriptomic analyses of trans-kingdom pathogen Fusarium solani species complex reveal degrees of compartmentalization.

Authors:  Daphne Z Hoh; Hsin-Han Lee; Naohisa Wada; Wei-An Liu; Min R Lu; Cheng-Kuo Lai; Huei-Mien Ke; Pei-Feng Sun; Sen-Lin Tang; Wen-Hsin Chung; Ying-Lien Chen; Chia-Lin Chung; Isheng Jason Tsai
Journal:  BMC Biol       Date:  2022-10-20       Impact factor: 7.364

6.  Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.

Authors:  Hazal Boral; Anne van Diepeningen; Elif Erdem; Meltem Yağmur; G Sybren de Hoog; Macit Ilkit; Jacques F Meis; Abdullah M S Al-Hatmi
Journal:  Mycopathologia       Date:  2018-06-21       Impact factor: 2.574

7.  Clinical and Mycological Features of Fungal Keratitis: A Retrospective Single-Center Study (2012-2018)

Authors:  İbrahim İnan Harbiyeli; Elif Erdem; Nuhkan Görkemli; Astan İbayev; Hazal Kandemir; Arbil Açıkalın; Macit İlkit; Meltem Yağmur
Journal:  Turk J Ophthalmol       Date:  2022-04-28

8.  South Indian Isolates of the Fusarium solani Species Complex From Clinical and Environmental Samples: Identification, Antifungal Susceptibilities, and Virulence.

Authors:  Mónika Homa; László Galgóczy; Palanisamy Manikandan; Venkatapathy Narendran; Rita Sinka; Árpád Csernetics; Csaba Vágvölgyi; László Kredics; Tamás Papp
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

9.  Cutaneous Fusariosis in a Patient with Job's (Hyper-IgE) Syndrome.

Authors:  Ahmed M Altibi; Radhika Sheth; Ayman Battisha; Vivek Kak
Journal:  Case Rep Infect Dis       Date:  2020-06-15

10.  Burden of serious fungal infections in the Netherlands.

Authors:  Jochem B Buil; Eelco F J Meijer; David W Denning; Paul E Verweij; Jacques F Meis
Journal:  Mycoses       Date:  2020-04-28       Impact factor: 4.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.